Trial intelligence / Profile preview

Simvastatin with XELIRI/FOLFIRI in Metastatic Colorectal Cancer

NCT01238094Phase 3Unknown

Sponsor
Samsung Medical Center
Start
Apr 2010
Primary completion
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of simvastatin in colorectal cancer (CRC), sponsored by Samsung Medical Center. Status: unknown.

02

Drugs

simvastatin
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT01238094.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01238094.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call